John R. Saksa

1.7k total citations
17 papers, 1.2k citations indexed

About

John R. Saksa is a scholar working on Clinical Psychology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, John R. Saksa has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Psychology, 9 papers in Psychiatry and Mental health and 7 papers in Experimental and Cognitive Psychology. Recurrent topics in John R. Saksa's work include Schizophrenia research and treatment (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (7 papers) and Obsessive-Compulsive Spectrum Disorders (5 papers). John R. Saksa is often cited by papers focused on Schizophrenia research and treatment (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (7 papers) and Obsessive-Compulsive Spectrum Disorders (5 papers). John R. Saksa collaborates with scholars based in United States and Australia. John R. Saksa's co-authors include Scott W. Woods, Barbara C. Walsh, Christopher Pittenger, Ralitza Gueorguieva, Michelle Hampson, Dustin Scheinost, Teodora Stoica, Thomas H. McGlashan, Suzanne Wasylink and Roy Money and has published in prestigious journals such as Journal of Consulting and Clinical Psychology, Biological Psychiatry and Schizophrenia Bulletin.

In The Last Decade

John R. Saksa

17 papers receiving 1.2k citations

Peers

John R. Saksa
John R. Saksa
Citations per year, relative to John R. Saksa John R. Saksa (= 1×) peers Lena Flyckt

Countries citing papers authored by John R. Saksa

Since Specialization
Citations

This map shows the geographic impact of John R. Saksa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Saksa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Saksa more than expected).

Fields of papers citing papers by John R. Saksa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Saksa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Saksa. The network helps show where John R. Saksa may publish in the future.

Co-authorship network of co-authors of John R. Saksa

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Saksa. A scholar is included among the top collaborators of John R. Saksa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Saksa. John R. Saksa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Woods, Scott W., John R. Saksa, Michael T. Compton, et al.. (2017). 112. Effects of Ziprasidone Versus Placebo in Patients at Clinical High Risk for Psychosis. Schizophrenia Bulletin. 43(suppl_1). S58–S58. 20 indexed citations
2.
Srihari, Vinod H., Cenk Tek, Suat Küçükgöncü, et al.. (2015). First-Episode Services for Psychotic Disorders in the U.S. Public Sector: A Pragmatic Randomized Controlled Trial. Psychiatric Services. 66(7). 705–712. 98 indexed citations
3.
Scheinost, Dustin, Teodora Stoica, Suzanne Wasylink, et al.. (2014). Resting state functional connectivity predicts neurofeedback response. Frontiers in Behavioral Neuroscience. 8. 338–338. 49 indexed citations
4.
Scheinost, Dustin, Teodora Stoica, John R. Saksa, et al.. (2013). Orbitofrontal cortex neurofeedback produces lasting changes in contamination anxiety and resting-state connectivity. Translational Psychiatry. 3(4). e250–e250. 127 indexed citations
5.
White, Kamila S., Laura A. Payne, Jack M. Gorman, et al.. (2012). Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial.. Journal of Consulting and Clinical Psychology. 81(1). 47–57. 32 indexed citations
6.
Hampson, Michelle, Teodora Stoica, John R. Saksa, et al.. (2012). Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety. Journal of Visualized Experiments. 22 indexed citations
7.
Woods, Scott W., Barbara C. Walsh, Keith A. Hawkins, et al.. (2012). Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies. European Neuropsychopharmacology. 23(8). 931–940. 48 indexed citations
8.
Hampson, Michelle, John R. Saksa, Dustin Scheinost, et al.. (2012). Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety. Journal of Visualized Experiments. 6 indexed citations
9.
Kantrowitz, Joshua T., Anil K. Malhotra, Barbara A. Cornblatt, et al.. (2010). High dose D-serine in the treatment of schizophrenia. Schizophrenia Research. 121(1-3). 125–130. 203 indexed citations
10.
Woods, Scott W., Barbara C. Walsh, John R. Saksa, & Thomas H. McGlashan. (2010). The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophrenia Research. 123(2-3). 199–207. 83 indexed citations
11.
Woods, Scott W., Hal Morgenstern, John R. Saksa, et al.. (2010). Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications. The Journal of Clinical Psychiatry. 71(4). 463–474. 146 indexed citations
12.
Saksa, John R., Shuki J. Cohen, Vinod H. Srihari, & Scott W. Woods. (2009). Cognitive Behavior Therapy for Early Psychosis: A Comprehensive Review of Individual vs. Group Treatment Studies. International Journal of Group Psychotherapy. 59(3). 357–383. 38 indexed citations
13.
Woods, Scott W., John R. Saksa, C. Bruce Baker, Shuki J. Cohen, & Cenk Tek. (2008). Effects of Levetiracetam on Tardive Dyskinesia. The Journal of Clinical Psychiatry. 69(4). 546–554. 61 indexed citations
14.
Aaronson, Cindy, M. Katherine Shear, Raymond R. Goetz, et al.. (2008). Predictors and Time Course of Response Among Panic Disorder Patients Treated With Cognitive-Behavioral Therapy. The Journal of Clinical Psychiatry. 69(3). 418–424. 71 indexed citations
15.
Srihari, Vinod H., Scott W. Woods, Brooks Walsh, et al.. (2006). 0205 SPECIALIZED TREATMENT EARLY IN PSYCHOSIS (STEP): A PRAGMATIC RANDOMIZED CONTROLLED TRIAL IN THE US PUBLIC SECTOR. Schizophrenia Research. 86. S165–S165. 7 indexed citations
16.
Coric, Vladimir, Sarper Taşkıran, Christopher Pittenger, et al.. (2005). Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial. Biological Psychiatry. 58(5). 424–428. 204 indexed citations
17.
Saksa, John R., C. Bruce Baker, & Scott W. Woods. (2004). Mood-stabilizer-maintained, remitted bipolar patients: taper and discontinuation of adjunctive antipsychotic medication. General Hospital Psychiatry. 26(3). 233–236. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026